 |
| Nifty futures tips |
The world wide market volatility of the previous month that sent US(United States) stocks to their worst Q(quarter) in 4 years shows no signs of letting up due to the calendar turned to October month. Read Other News Nifty futures tips
Fund managers say they are bracing for another leg down in the S&P 500 stock index, after it fell more than 10 per cent from the record high it reached May 20, and they are starting to increase cash and other defensive positions in their portfolios.
A weaker than estimated US(United States) employment report for September published on Friday, lowered the inflation assumptions & the prospects for a dim US(United States) corporate earnings season, are all factors fanning worries that the economic recovery may be derailed.
The Fed Reserve's decision in September month to delay raising interest rates from financial crisis-era levels is exacerbating the unstability behind the market's large swings, told by Jonathan Golub, chief US market strategist at RBC Capital Markets.
Biotechnology & Healthcare stocks look particularly attractive, he told, after the Nasdaq Biotechnology Index fell nearly 20 per-cent over 7 trading days recently in the wake of a vow by Democratic presidential candidate Hillary Clinton to take effective steps to restrain high prices of drug.
But the market still continues to narrow & narrow. We're not about to fell into a bear market, but I'm starting to think the raging bull market is over," he told.
Fund managers say they are bracing for another leg down in the S&P 500 stock index, after it fell more than 10 per cent from the record high it reached May 20, and they are starting to increase cash and other defensive positions in their portfolios.
A weaker than estimated US(United States) employment report for September published on Friday, lowered the inflation assumptions & the prospects for a dim US(United States) corporate earnings season, are all factors fanning worries that the economic recovery may be derailed.
The Fed Reserve's decision in September month to delay raising interest rates from financial crisis-era levels is exacerbating the unstability behind the market's large swings, told by Jonathan Golub, chief US market strategist at RBC Capital Markets.
Biotechnology & Healthcare stocks look particularly attractive, he told, after the Nasdaq Biotechnology Index fell nearly 20 per-cent over 7 trading days recently in the wake of a vow by Democratic presidential candidate Hillary Clinton to take effective steps to restrain high prices of drug.
But the market still continues to narrow & narrow. We're not about to fell into a bear market, but I'm starting to think the raging bull market is over," he told.
Read Other News Nifty futures tips
No comments:
Post a Comment